Improving the lives of our patients.
We work tirelessly to create life changing treatments that help our patients live better and fuller lives.
Learn More
Research & Development
We invest in innovative research and development through our own development or partnerships to best address the unmet needs of patients
Learn More
About Us
We are a privately held pharmaceutical company focused on oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.
Learn More
— Research & Development
Oncology Pipeline
We continue to build our treatment portfolio with a current focus on oncology within the United States.
Learn More— Join Our Team
See a Future at Servier?
Learn more about working at Servier and search our current job openings to see if there is a career opportunity for you.
Learn More
Latest News
#BreakingNews: Today we announced the FDA has approved our treatment for previously treated IDH1-mutated cholangiocarcinoma.
Learn More
Today marks our three year #anniversary in the U.S!
Learn More
Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in IDH1-Mutated Cholangiocarcinoma
Learn MoreAdobe Stock©Mat Hayward | Adobe Stock©REDPIXEL | Adobe Stock©Gorodenkoff | Adobe Stock©Monkey Business